Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $9.93 in the prior trading day, Vir Biotechnology Inc (NASDAQ: VIR) closed at $9.54, down -3.93%. In other words, the price has decreased by -$3.93 from its previous closing price. On the day, 1.01 million shares were traded. VIR stock price reached its highest trading level at $9.89 during the session, while it also had its lowest trading level at $9.49.
Ratios:
Our goal is to gain a better understanding of VIR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.90 and its Current Ratio is at 12.90. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $23 previously.
On September 08, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $23 to $14.
JP Morgan Upgraded its Neutral to Overweight on March 06, 2023, whereas the target price for the stock was revised from $35 to $34.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 03 ’24 when De Backer Marianne sold 72,995 shares for $9.46 per share. The transaction valued at 690,365 led to the insider holds 678,457 shares of the business.
HANLY ANN M. sold 2,711 shares of VIR for $27,251 on Apr 01 ’24. The EVP & Chief Technology Officer now owns 132,069 shares after completing the transaction at $10.05 per share. On Mar 27 ’24, another insider, Lee Sung, who serves as the EVP & Chief Financial Officer of the company, sold 6,008 shares for $9.89 each. As a result, the insider received 59,404 and left with 100,492 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VIR now has a Market Capitalization of 1298002944 and an Enterprise Value of 322383680. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.31 while its Price-to-Book (P/B) ratio in mrq is 0.84. Its current Enterprise Value per Revenue stands at 4.05 whereas that against EBITDA is -0.557.
Stock Price History:
Over the past 52 weeks, VIR has reached a high of $27.48, while it has fallen to a 52-week low of $7.61. The 50-Day Moving Average of the stock is -2.22%, while the 200-Day Moving Average is calculated to be -5.96%.
Shares Statistics:
The stock has traded on average 1.04M shares per day over the past 3-months and 1099280 shares per day over the last 10 days, according to various share statistics. A total of 134.78M shares are outstanding, with a floating share count of 89.11M. Insiders hold about 34.50% of the company’s shares, while institutions hold 52.93% stake in the company. Shares short for VIR as of 1713139200 were 5148714 with a Short Ratio of 4.94, compared to 1710460800 on 5430466. Therefore, it implies a Short% of Shares Outstanding of 5148714 and a Short% of Float of 6.2.
